Article
DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group.
Leukemia - 1 Feb 2008
Bhatla D, Gerbing R B, Alonzo T A, Mehta P A, Deal K, Elliott J, Meshinchi S, Geiger H, Perentesis J P, Lange B J, Davies S M
Abstract excerpt
Polymorphisms of DNA repair genes RAD51 and XRCC3 increase susceptibility to acute myeloid leukemia (AML) in adults, an effect enhanced by deletion of the glutathione-S-transferase M1 (GSTM1) gene. In this study, we genotyped 452 children with de novo AML treated on CCG protocols 2941 and 2961 and compared genotype frequencies with those of normal blood donors, and analyzed the impact of genotype on outcome of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
